Extensive proteolytic degradation of recombinant proteins is a recurrent problem with the commonly utilized baculovirus expression system (5) . In this work, we describe modifications to the expression and purification of the transcriptional coactivator SRC-1 in a baculovirus system that increase both the yield and purity of the recovered protein and that can potentially be applied to other recombinant proteins. SRC-1 is a 160-kDa protein that interacts with the ligand binding domain of steroid receptors and modulates transcription at steroid-regulated promoters (9) . The study of SRC-1 in cell-free assays has been limited by difficulties in producing full-length recombinant protein. Previous purification of small amounts of full-length SRC-1 required injection of mRNA synthesized in vitro that encode Flag ® -tagged SRC-1 into Xenopus oocytes (4) . Since injection of Xenopusoocytes is a laborious procedure, we choose to express SRC-1 in Spodoptera frugiperda -derived Sf9 insect cells using a baculovirus expression system. The baculovirus expression system has proven to be advantageous over other methods for the expression of recombinant eukaryotic proteins because it often yields greater amounts of post-translationally modified and correctly folded protein essential for biological activity (7) .
Using a baculovirus expression system, we determined whether tagging SRC-1 with a Flag epitope tag on the amino or carboxyl terminus affected its expression and degradation. The use of a carboxyl-terminal epitope tag has been suggested to be more effective for affinity purification of large proteins than an amino terminal tag (3). We generated pVL 1393 baculovirus transfer vectors (Invitrogen, Carlsbad, CA, USA) containing human SRC-1a with a Flag epitope tag on either the amino terminus (Flag-SRC) or the carboxyl terminus (SRC-Flag). We chose a Flag epitope tag since immunoaffinity purification of Flag-tagged SRC-1 from Xenopus oocytes resulted in a biologically active protein (4) . The recombinant baculovirus transfer vectors were co-transfected with linear AcMNPV DNA (Invitrogen) into Sf9 cells, and recombinant baculoviruses were isolated by plaque assay.
To express and purify full-length SRC-1, Sf9 cells were inoculated with virus at a multiplicity of infection of 1 and allowed to grow for 48 h at 27°C. Cells were harvested by centrifugation at 400 ×gfor 15 min, washed once in TG buffer (10 mM Tris-HCl, pH 8.0, and 10% glycerol) and frozen as pellets at -80°C. The Sf9 cells were lysed in a homogenization buffer [20 mM TrisHCl, pH 7.5, 500 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 2 mM DTT, 20% glycerol, 1 mM phenylmethylsulfonyl fluoride (PMSF), 20 µ g/mL leupeptin, and 20 µ g/mL aprotinin]. The cell lysate was homogenized and centrifuged at 100 000 ×gfor 30 min, and the supernatant was taken as a soluble whole cell extract (WCE). The WCE was diluted 1:2 in a dilution buffer (20 mM Tris-HCl, pH 7.5, 1.5 mM MgCl 2 , 0.2 mM EDTA, 2 mM DTT, 10% glycerol, 1 mM PMSF, 20 µ g/mL leupeptin, 20 µ g/mL aprotinin, and 0.5% Nonidet ® P-40) and added to anti-Flag M2 resin (Sigma, St. Louis, MO, USA) equilibrated with dilution buffer. The WCE was incubated with resin on a rotator for 4 h. The resin was washed extensively in a wash buffer (20 mM TrisHCl, pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 2 mM DTT, 10% glycerol, 1 mM PMSF, and 0.2% Nonidet P-40). SRC-1 was eluted by incubating the resin with an elution buffer [20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2 mM DTT, 15% glycerol, 0.1% Nonidet P-40, 0.2 mg/mL Flag peptide (Sigma), 0.5 mg/mL insulin, and 1 mM PMSF].
We determined the amount of SRC-1 that was degraded in the WCE and in the protein eluted from the anti-Flag affinity resin (eluate) using the SRC-1 mouse monoclonal antibody 1135/H4 (8) . Five microliters of the 10-mL WCE and 5 µ L of the 1-mL eluate were analyzed. As illustrated in Figure 1A , there was substantial degradation of both Flag-SRC and SRC-Flag in the WCE (lanes 1 and 3) . However, in contrast to Flag-SRC (lane 2), fewer degradation products were observed in the SRC-Flag eluate (lane 4). This result indicated that use of a Flag epitope tag on the carboxyl terminus of SRC-1 increased our ability to purify full-length protein. Since the epitope to the SRC-1 antibody is located in the central portion of SRC-1, between amino acids 361-1139, it is possible that small degradation fragments were not detected because of the removal of the epitope (8) . However, small molecular weight contaminants were not observed in SRC-Flag eluates analyzed by Coomassie ® blue staining, although characteristic bands of 130 and 85 kDa were seen. These bands probably represent SRC-1 degradation products (see below and Figure 1B, lane 6) .
Although the use of a Flag tag on the carboxyl terminus increased the purity of eluted SRC-1, the overall yield of full-length protein was rather low. In an effort to further increase the yield and purity of SRC-1, we coexpressed SRCFlag with the human progesterone receptor (PR). PR and SRC-1 have been shown to form a stable steady state complex in vivo upon the addition of hormone (6) . Therefore, we reasoned that coexpression of SRC-Flag with PR and hormone might stabilize the coactivator and thereby increase the yield and purity of full-length SRC-1. Coexpression of recombinant baculoviruses has been used previously to produce multisubunit protein complexes (1) . In this experiment, Sf9 cells were inoculated with baculoviruses containing SRCFlag and a histidine-tagged PR (8) at a multiplicity of infection of 1.0 and allowed to grow for 48 h at 27°C. Promegestone (200 nM; R5020) (NEN Life Sciences, Boston, MA, USA) was added 24 h before harvesting. SRCFlag was purified with an anti-Flag affinity resin as described above, except that 2.5 µ M of a 13-amino-acid peptide (KHKILHRLLQDSS) corresponding to the second nuclear receptor box LXXLL motif in SRC-1 (NR-2) was added to the diluted WCE and incubated with the resin on a rotator for 4 h at 4°C. Incubation of the WCE with the NR-2 peptide prevented PR from bindBenchmarks ing to SRC-1 during the purification process and permitted the complete separation of SRC-1 from PR on the anti-Flag affinity resin.
When coexpressed with PR, the yield of full-length SRC-1 increased 4-fold to 0.4 mg/500-mL flask of Sf9 cells. In addition to increasing the yield, the presence of the hormone-bound receptor reduced contaminants in the eluate that we presume to be SRC-Flag degradation products ( Figure 1B) . We loaded 10 µ L eluate in lane 5 and 40 µ L eluate in lane 6 to compare the purity of full-length SRC-1 when coexpressed with PR and R5020 or when expressed by itself. We estimated that the purity of full-length SRC-1 was greater than 95% when coexpressed with PR compared to 80% when SRC-1 was expressed alone. Western analysis revealed no detectable levels of PR contamination in the eluate (data not shown).
Once we had obtained purified, fulllength SRC-1, we tested its activity in a cell-free transcription assay employing an estrogen responsive promoter. Chromatin assembly reactions were performed with an S190 extract derived from postblastoderm Drosophilaembryos (0-6 h) as described previously (2) . The S190 extract was incubated with rabbit reticulocyte lysate (Green Hectares, Oregon, WI, USA) and purified Drosophilacore histones for 30 min at room temperature. In a separate tube, the estrogen receptor (ER α ), 17 β -estradiol (Sigma) and the plasmid DNA template were incubated on ice for 15 min. The Flag-tagged ER αwas purified as described previously (2) . The pERE 2 S2CAT template contained two consensus estrogen response elements (5 ′ -AGGTCACAGTGACCT-3 ′ ) upstream of a minimal S2 promoter linked to the chloramphenicol acetyltransferase (CAT) gene. The S190-histone and the ER α -template mixture was combined with an ATP regeneration mixture (20 mM ATP, 0.2 M creatine phosphate, 650 µ g/mL creatine phosphokinase, and 30 mM MgCl 2 ), and the mixture was incubated at 27°C for 4 h. SRC-1 was added to the chromatin after the assembly reaction was complete and incubated for 20 min at room temperature to allow interaction of the coactivator with the pre-assembled chromatin. In the samples with naked templates, the reactions lacked core histones. In vitro transcription reactions were performed with HeLa cell nuclear extracts as described previously (2 Figure 2 . Purified, recombinant SRC-1 is active in a cell-free transcription assay. The ability of SRC-1 to modulate ER-dependent transcription was measured in a cell-free transcription assay employing a DNA template containing two consensus estrogen response elements. The plasmid, ERE 2 S2CAT was used as a naked template or assembled into chromatin. ER α , 17 β -estradiol (E 2 ), and SRC-1 were added as indicated. The final concentrations of ER α , E 2 , and SRC-1 in the transcription reactions were 5, 15, and 25 nM, respectively. The samples were subjected to in vitro transcription and primer extension analysis. The data were quantitated using a PhosphorImager ® (Amersham Biosciences, Piscataway, NJ, USA). The amount of transcription relative to basal transcription is indicated. To determine whether the purified SRC-1 was functional, we measured the effect of SRC-1 on ER α -dependent transcription on naked and chromatin templates. As expected, there was an increase in ER α -dependent transcription upon the addition of hormone on naked and chromatin templates ( Figure  2) . With the addition of purified SRC-1, there was a synergistic increase in transcriptional activity on both naked and chromatin templates, indicating that SRC-1 was functionally active. We also noted that the actual level of coactivation by SRC-1 is likely to be higher since there is some endogenous SRC-1 in the HeLa cell nuclear extract.
In summary, we have described strategies that optimize the expression and recovery of full-length SRC-1 expressed in Sf9 insect cells using a modified baculovirus expression system. The modifications included using a C-terminal Flag epitope tag and coinfection of hormone-bound PR with Flag-tagged SRC-1. This approach resulted in a high yield of functional, full-length protein. Our studies will facilitate the analysis of the coactivator activity of SRC-1 in a cell-free transcription assay. In addition, similar procedures could be applied to other recombinant proteins that exhibit extensive proteolytic degradation.
